Clinical Trial Update: Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the combination of paclitaxel and bortezomib in patients with metastatic or unresectable malignant solid tumors, incl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Head and Neck Cancer
• Lung Cancer
• Melanoma
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer

Drugs mentioned

• Bortezomib (Velcade) (Bortezomib)
• Paclitaxel (Taxol) (paclitaxel)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Breast Cancer, Colorectal Cancer | Phase 1 | Status: COMPLETED